Analysis BioTech Life Science 
Health Populi
JUNE 24, 2021
We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? Translation: watch out for winter and flu season, especially if people don’t re-mask and take care to protect themselves and others — particularly important in geographies where more folks have opted out of getting vaccinated.
Healthcare IT Today
APRIL 25, 2024
By leveraging AI and big data analysis, the company aims to streamline the drug discovery process, making it faster, cheaper, and more predictable. Reflecting on AION Lab’s role in nurturing biotech startups, Gill underscores the company’s commitment to fostering innovation and supporting the growth of emerging ventures.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT Today
MARCH 22, 2023
The following is a guest article by Steve Lazer, Global Healthcare & Life Sciences CTO at Dell Technologies. The primary use cases for cognitive AI in biotech include accelerating data analysis, automating document management, improving collaboration, and reducing risk of human error.
Health Populi
APRIL 24, 2019
In this study, the healthcare industry is comprised of five segments: hospitals and clinics; pharma; biotech (separate from pharma); consumer health (e.g., Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. over-the-counter medicines); and, health insurance.
Digital Health Global
NOVEMBER 20, 2023
With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. Please visit astrazeneca.com and follow the Company on Social Media @ AstraZeneca. Available at: [link]. Accessed November 2023.
Healthcare IT Today
SEPTEMBER 13, 2024
Funding will Support Expanded Commercialization Efforts for PreciseBreast Risk Assessment PreciseDx , a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for new, morphology-driven disease analysis, today announced that it has raised $20.7 million in Series B funding, bringing its total funding to date to $31.5
Digital Health Global
FEBRUARY 5, 2024
Investment Marks a Significant Milestone in Advancing AI-Based Arrhythmia Care SAN DIEGO–(BUSINESS WIRE)– Vektor Medical , a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science.
Expert insights. Personalized for you.
270 
Let's personalize your content